CAH Insider Trading

Insider Ownership Percentage: 0.09%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $12,379,979.50

Cardinal Health Insider Trading History Chart

This chart shows the insider buying and selling history at Cardinal Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10M-$5M$0$5M$10MTotal Insider BuyingTotal Insider Selling

Cardinal Health Share Price & Price History

Current Price: $136.43
Price Change: Price Decrease of -0.219 (-0.16%)
As of 03/28/2025 04:59 PM ET

This chart shows the closing price history over time for CAH up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$136.43Closing price on 03/30/25:

SEC Filings (Institutional Ownership Changes) for Cardinal Health (NYSE:CAH)

87.17% of Cardinal Health stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CAH by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$2.42Bbought$2.10BsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2B$0$2BTotal InflowsTotal Outflows
Cardinal Health logo
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Read More on Cardinal Health

Today's Range

Now: $136.43
Low: $135.93
High: $137.18

50 Day Range

MA: $128.36
Low: $123.56
High: $136.90

52 Week Range

Now: $136.43
Low: $93.17
High: $137.18

Volume

1,873,170 shs

Average Volume

2,104,262 shs

Market Capitalization

$32.96 billion

P/E Ratio

25.45

Dividend Yield

1.52%

Beta

0.66

Who are the company insiders with the largest holdings of Cardinal Health?

Cardinal Health's top insider shareholders include:
  1. Jason M Hollar (CEO)
  2. Jessica L Mayer (Insider)
  3. Deborah Weitzman (CEO)
  4. Stephen M Mason (CEO)
  5. Aaron E Alt (CFO)
  6. Michelle D Greene (Insider)
  7. Mary C Scherer (CAO)
Learn More about top insider investors at Cardinal Health.

Who are the major institutional investors of Cardinal Health?

Cardinal Health's top institutional investors include:
  1. Vanguard Group Inc. — 12.74%
  2. Geode Capital Management LLC — 2.43%
  3. FMR LLC — 1.74%
  4. Invesco Ltd. — 1.32%
  5. Marshall Wace LLP — 1.30%
  6. Northern Trust Corp — 1.26%
Learn More about top institutional investors of Cardinal Health stock.

Which institutional investors are selling Cardinal Health stock?

During the previous quarter, CAH stock was sold by these institutional investors:
  1. Pacer Advisors Inc.
  2. Arrowstreet Capital Limited Partnership
  3. Ameriprise Financial Inc.
  4. Jacobs Levy Equity Management Inc.
  5. AQR Capital Management LLC
  6. American Century Companies Inc.
  7. Two Sigma Advisers LP
  8. Legal & General Group Plc
In the previous year, company insiders that have sold Cardinal Health company stock include:
  1. Jason M Hollar (CEO)
  2. Jessica L Mayer (Insider)
  3. Deborah Weitzman (CEO)
  4. Stephen M Mason (CEO)
Learn More investors selling Cardinal Health stock.

Which institutional investors are buying Cardinal Health stock?

During the last quarter, CAH stock was bought by institutional investors including:
  1. Norges Bank
  2. Marshall Wace LLP
  3. Castlekeep Investment Advisors LLC
  4. Junto Capital Management LP
  5. Woodline Partners LP
  6. 8 Knots Management LLC
  7. Bank of Nova Scotia
  8. Oribel Capital Management LP